Get started
Author

Martin Friede

New horizons in adjuvants for vaccine development
2008 · Steven G. Reed, Sylvie Bertholet, et al. · Trends in Immunology · 675
Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
2011 · Rhea N. Coler, Sylvie Bertholet, et al. · PLoS ONE · 312
PDF
Intradermal delivery of vaccines: potential benefits and current challenges
2011 · JK Hickling, KR Jones, et al. · Bulletin of the World Health Organization · 195
PDF
A review of human vaccine research and development: Malaria
2006 · Marc P. Girard, Zarifah H. Reed, et al. · Vaccine · 147
Randomized Controlled Clinical Trial of Fractional Doses of Inactivated Poliovirus Vaccine Administered Intradermally by Needle‐Free Device in Cuba
2010 · Sonia Resik, Alina Tejeda, et al. · The Journal of Infectious Diseases · 146
Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: A World Health Organization Action Framework
2021 · Johan Vekemans, Mateusz Hasso-Agopsowicz, et al. · Clinical Infectious Diseases · 124
PDF
Bacillus Calmette-Guérin (BCG) vaccine: A global assessment of demand and supply balance
2017 · Tania Cernuschi, Stefano Malvolti, et al. · Vaccine · 122
PDF
Therapeutic antibodies for infectious diseases
2017 · Erin Sparrow, Martin Friede, et al. · Bulletin of the World Health Organization · 120
PDF
Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations
2009 · Ryan C. Anderson, Christopher B. Fox, et al. · Colloids and Surfaces B Biointerfaces · 103
WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: Supporting developing country production capacity through technology transfer
2011 · Martin Friede, Laszlo Palkonyay, et al. · Vaccine · 102
PDF
FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10–11, 2007
2008 · Maryna Eichelberger, Hana Golding, et al. · Vaccine · 93
Antigenicity and immunogenicity of modified synthetic peptides containing D-amino acid residues. Antibodies to a D-enantiomer do recognize the parent L-hexapeptide and reciprocally.
1993 · N Benkirane, M Friede, et al. · Journal of Biological Chemistry · 87
A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future
2021 · Kristine A. Moore, Julia T. Ostrowsky, et al. · Vaccine · 75
PDF
Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics
2018 · Johan Vekemans, Vasee Moorthy, et al. · Vaccine · 72
PDF
Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications
2016 · Erin Sparrow, Martin Friede, et al. · Vaccine · 67
PDF
Synthetic and Natural TLR4 Agonists as Safe and Effective Vaccine Adjuvants
2010 · Christopher B. Fox, Martin Friede, et al. · Sub-cellular biochemistry/Subcellular biochemistry · 65
Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems
2004 · M FRIEDE, M AGUADO · Advanced Drug Delivery Reviews · 65
Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22–23 March 2017
2018 · M. Teresa Aguado, Jane Barratt, et al. · Vaccine · 64
PDF
Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics
2018 · Johan Vekemans, Vasee Moorthy, et al. · Vaccine · 62
Seasonal influenza vaccination policies in the 194 WHO Member States: The evolution of global influenza pandemic preparedness and the challenge of sustaining equitable vaccine access
2021 · Kathleen F. Morales, David W. Brown, et al. · Vaccine X · 61
PDF
Adjuvants for malaria vaccines
2009 · R. N. COLER, D. CARTER, et al. · Parasite Immunology · 59
PDF
Advancing influenza vaccines: A review of next-generation candidates and their potential for global health impact
2024 · Jessica Taaffe, Julia T. Ostrowsky, et al. · Vaccine · 54
Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans
2007 · N ETCHART, A HENNINO, et al. · Vaccine · 54
Induction of immune response against a short synthetic peptide antigen coupled to small neutral liposomes containing monophosphoryl lipid a
1993 · Martin Friede, Sylviane Muller, et al. · Molecular Immunology · 54
Malaria Vaccine Development: Progress and Challenges
2006 · Z. Reed, M. Friede, et al. · Current Molecular Medicine · 40
Works count: 79
Citation count: 3,690
H-index: 32
I10-index: 50
Year
Topic
Type